Kiyoshi Asada

Kashihara-shi, 6348522, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Response to "Comment on 'Using Serum Creatinine-To-Cystatin C Ratio to Predict Sarcopenia in Patients With Liver Cirrhosis'".

Response to "Comment on 'Using Serum Creatinine-To-Cystatin C Ratio to Predict Sarcopenia in Patients With Liver Cirrhosis'".

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 21, 2026

Long-Term Effects of Nalmefene on Alcohol Consumption, Liver Function, and Gut Microbiota in Patients With Alcohol-Related Liver Disease.

Long-Term Effects of Nalmefene on Alcohol Consumption, Liver Function, and Gut Microbiota in Patients With Alcohol-Related Liver Disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 18, 2026

Glucosyl hesperidin benefits in primary biliary cholangitis: a multicenter, open-label, randomized controlled study.

Glucosyl hesperidin benefits in primary biliary cholangitis: a multicenter, open-label, randomized controlled study.

Journal: Clinical and translational gastroenterology

Published: February 24, 2026

Haemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative: an open-label, single-centre phase Ib study protocol in Japan.

Haemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative: an open-label, single-centre phase Ib study protocol in Japan.

Journal: BMJ open

Published: January 22, 2026

Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Hepatitis-C-Associated Liver Cirrhosis After Achieving a Sustained Virologic Response.

Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Hepatitis-C-Associated Liver Cirrhosis After Achieving a Sustained Virologic Response.

Journal: Current issues in molecular biology

Published: January 06, 2026

Sex-specific associations between annual kidney function changes and weight/waist changes in overweight Japanese: Japan Specific Health Checkup cohort.

Sex-specific associations between annual kidney function changes and weight/waist changes in overweight Japanese: Japan Specific Health Checkup cohort.

Journal: Endocrine journal

Published: October 01, 2025

The 7S Domain of Type IV Collagen as a Noninvasive Surrogate of Portal Hypertension.

The 7S Domain of Type IV Collagen as a Noninvasive Surrogate of Portal Hypertension.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: September 27, 2025

Using Serum Creatinine-to-Cystatin C Ratio to Predict Sarcopenia in Patients With Liver Cirrhosis.

Using Serum Creatinine-to-Cystatin C Ratio to Predict Sarcopenia in Patients With Liver Cirrhosis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: August 25, 2025

Creatinine-to-Cystatin C Ratio Combined with FIB-4 and ELF for Noninvasive Fibrosis Assessment in MASLD.

Creatinine-to-Cystatin C Ratio Combined with FIB-4 and ELF for Noninvasive Fibrosis Assessment in MASLD.

Journal: International journal of molecular sciences

Published: August 20, 2025

Marked Increase in Zinc Concentration of Ascitic Fluid After Cell-free and Concentrated Ascites Reinfusion Therapy in Patients With Cirrhotic Refractory Ascites: A Retrospective Observational Study.

Marked Increase in Zinc Concentration of Ascitic Fluid After Cell-free and Concentrated Ascites Reinfusion Therapy in Patients With Cirrhotic Refractory Ascites: A Retrospective Observational Study.

Journal: In vivo (Athens, Greece)

Published: August 15, 2025

Lipopolysaccharide Binding Protein and Soluble Mannose Receptor as Biomarkers for Acute Kidney Injury in Cirrhosis.

Lipopolysaccharide Binding Protein and Soluble Mannose Receptor as Biomarkers for Acute Kidney Injury in Cirrhosis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: August 07, 2025

The Macrophage Activation Marker Soluble CD163 Predicts the Response to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma.

The Macrophage Activation Marker Soluble CD163 Predicts the Response to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma.

Journal: Anticancer research

Published: June 13, 2025

Showing 1-12 of 46

Last Updated: 09/26/2026